inVentiv Health announced two appointments. Dan Rubin has been named president of inVentiv patient outcomes. Norman Stalsberg has been named president of inVentiv strategy & analytics. “Dan and Norman both have outstanding leadership experience and vision, having grown small ventures into thriving businesses. I believe the skills and perspective they bring to these new roles will be a tremendous asset to our organization,” said Blane Walter, CEO of inVentiv Health. Here’s the release.

eResearch Technologypicked Keith Schneck as executive VP and CFO. He joins eRT with over 30 years of senior financial experience and executive management expertise in high growth companies and public accounting. “We are excited to have someone of Keith’s expertise and talent join eRT. His previous experience as a public company CFO and a chief operating officer will be important as we continue to grow and implement our future strategy,” said Michael McKelvey, president and CEO of eRT.

Lab Research announced the financial results for the second quarter of 2008. “In the second quarter of 2008, our Canadian and Danish sites continued to yield excellent performance and profit growth. Their combined revenues increased by 19 percent compared to the results achieved in the second quarter of 2007, while their combined adjusted EBITDA increased by 11 percent. The company’s overall financial performance was still affected by our Hungarian site, which recorded sales of $1.3 million in the second quarter of the current fiscal year due to slow study starts,” said Luc Mainville, president and CEO.

Metroplex Clinical Research Center (MCRC) in Dallas has enjoyed a 250 percent increase in business since site executives announced plans to reclaim assets from Radiant Research in March 2007. Last year’s re-purchase came eight years after Seattle-based Radiant Research assumed control of MCRC in 1999. “Over the last year, the physicians at MCRC have become more involved in Phase I research,” explained medical director Roy Fleischmann. Here’s the release.d9A2t49mkex

Electronic data capture supplier Clinipace announced that On-X Life Technologies has saved over $2 million in direct and indirect costs associated with conducting two research studies using its software. Here’s the release.

FDA announced new rules barring advisory committee members with financial interest exceeding $50,000 in a company being reviewed by an advisory committee. It’s not clear whether the rule will exclude any current advisory committee members. News reports suggest that the agency has not had difficulty attracting newscientists to serve in that capacity, with more than 300 resumes received so far. Here’s the press release.

Have a news release? Send it to .